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PreviewsThe inability of Erk2 to adopt the
canonical aC-helix out conformation is
likely due to the presence of a unique
insertion domain found in MAPKs (L16
segment) that can prevent movement of
the aC-helix. The L16 segment is found
to occupy similar space as cyclin A bind-
ing of Cdk2, a binding event that prevents
Cdk2 from adopting the aC-helix out
conformation (Schulze-Gahmen et al.,
1996) (Figure 2). Similar to the ability of
Syk kinase to bind DFG-out ligands in
an active conformation (e.g., imatinib),
these results highlight the importance of
structurally characterizing conformation-
ally selective inhibitors with their target
kinase.
This work, together with previous re-
ports, highlights the large range of allo-steric effects that some kinase inhibitors
can modulate. These allosteric effects
are neglected in most reports of kinase in-
hibitor development; however, the ability
of select inhibitors to modulate noncata-
lytic function can have profound pharma-
cological consequences when applying
these kinase inhibitors to cellular systems.
A picture is emerging that DFG-out inhib-
itors (and some aC-helix out inhibitors)
have the ability to disrupt noncatalytic
kinase function, while active conforma-
tion inhibitors do not. These new findings
increase the complexity of predicting
outcomes for kinase inhibitors, but,
nevertheless, studies similar to this work
are essential to reveal the vast array of ac-
tivities that can emerge from kinase
inhibitors.Chemistry & Biology 21, May 22, 2014REFERENCES
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In this issue of Chemistry & Biology, Kirkpatrick and Viollier describe a new twist in the relationship between
bacterial cell development and antibiotic resistance. They reveal that TipN, which orchestrates development
at cell poles, is required to tolerate induced expression of an antibiotic efflux pump.The utility of antibiotics as therapeutics
lies in their selective inhibition of prokary-
otic pathways. With the increasing preva-
lence of antibiotic resistance, identifica-
tion of novel prokaryotic targets for the
development of new classes of antibiotics
is essential. The article by Kirkpatrick and
Viollier (2014) in this issue of Chemistry &
Biology suggests that proteins involved
in bacterial cell polarity determination
could serve as targets for combination
therapeutic agents that enhance the effi-
cacy of current antibiotics, even in strains
that are resistant. The model a-proteo-
bacterium Caulobacter crescentus is
resistant to the quinolone antibiotic Nali-
dixic acid (Nal) owing to a polymorphism
in DNA gyrase, the target of Nal. Kirkpa-
trick and Viollier (2014) show that disrup-tion of a cell polarity factor, TipN, which
marks the new cell pole and the site of
flagellar assembly (Huitema et al., 2006;
Lam et al., 2006), sensitizes Caulobacter
to Nal and restores antibiotic toxicity by
a novel mechanism.
Bacterial resistance to antibiotics
typically arises by one of three mecha-
nisms: (1) alteration of the drug target
such that the drug can no longer bind,
(2) modification or degradation of the
drug itself, or (3) acquisition or enhanced
expression of efflux pumps that expel the
drug from the cell. The first two mecha-
nisms can confer resistance to one or a
few very closely related antibiotics. Efflux
systems, on the other hand, can trans-
port a large repertoire of chemically
unrelated molecules. Thus induction ofsuch systems presents a mechanism
by which bacteria acquire resistance
to broad groups of antibiotics (Putman
et al., 2000).
The resistance-nodulation-division
(RND) transporters represent an impor-
tant family of efflux systems that are
capable of transferring molecules directly
from the cytoplasm or the periplasm to
the exterior of the cell. These tripartite
systems, typified by AcrAB-TolC, have
components in the inner membrane
(AcrB), the periplasm (AcrA), and the outer
membrane (TolC) that together form a
continuous vehicle to export molecules
from the cell (Fernando and Kumar,
2013). Expression of these systems is
often regulated by a TetR-like transcrip-
tional repressor that controls transcriptionª2014 Elsevier Ltd All rights reserved 571
Figure 1. The Cell Pole Marker, TipN, Is Required for Growth in Nalidixic Acid
Nal induces expression of the AcrAB2-NodT efflux pump by inhibiting the binding of the TipR repressor to
the acrAB2-nodT promoter. Increased expression of this efflux pump is not tolerated in cells lacking TipN.
This opens several questions (in green). Does TipR regulate other genes, which perhaps are involved in
development? What is the physiological role of AcrAB2-NodT; what are its substrates and how does it
regulate TipR and its own expression? What is the functional and spatiotemporal relationship between
this efflux pump and TipN?
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Previewsof the transporter operon in response to
interaction with a ligand.
Kirkpatrick and Viollier (2014) identified
an unexpected synthetic interaction be-
tween TipN and an RND-family efflux
system, AcrAB2-NodT. This discovery
stemmed from the observation that
TipN is required for growth in the pres-
ence of Nal. However, the Nal sensitivity
of cells lacking tipN is not due to inhibi-
tion of gyrase. Rather, Nal modulates
the activity of TipR, a previously unchar-
acterized TetR-family transcription fac-
tor, and a negative regulator of genes
encoding AcrAB2-NodT (Figure 1). Nal
induces expression of the efflux pump,
which Kirkpatrick and Viollier (2014)
demonstrate is able to excrete both Nal
and Cipro, a related gyrase inhibitor.
Interestingly, DtipN cells are not sensitive
to Nal per se, but instead are sensitive to
induction of this efflux pump; deletion of
acrAB2-nodT restores Nal resistance to
DtipN strains. This finding is paradoxical
and seems to go against the paradigm
that upregulation of efflux pumps confers
protection from antibiotics. This finding
also demonstrates an alternative mode
of growth inhibition by Nal that is inde-
pendent of gyrase and suggests that
acrAB2-nodT plays a role in cellular
development.572 Chemistry & Biology 21, May 22, 2014 ªThe mechanism underlying the syn-
thetic relationship between the TipN
polarity factor and this efflux system re-
mains to be determined. The efflux activ-
ity of AcrAB2-NodT is not required to
confer sensitivity to Nal; chemical inhibi-
tion of AcrAB2 does not restore Nal resis-
tance. Moreover, overexpression of either
AcrA or AcrB2 is not sufficient to confer
Nal sensitivity in DtipN cells. Overexpres-
sion of the TipR transcriptional repressor
boosts resistance to Nal in cells lacking
tipN and also in wild-type cells. This
observation in wild-type cells suggests
either that enhanced repression of
acrAB2-tolC is protective or that modula-
tion of TipR activity by Nal at secondary
sites in the genome has fitness conse-
quences, or both.
Notably, efflux pumps have been impli-
cated in growth and division regulation in
other prokaryotes. In Escherichia coli,
AcrAB functions as the primary efflux sys-
tem, while the closely related AcrEF sys-
tem apparently plays a role in cell division;
both efflux systems utilize the outer mem-
brane channel TolC. The inner membrane
protein AcrF is required for proper cell di-
vision when the periplasmic components,
AcrA or AcrE, are overexpressed (Lau and
Zgurskaya, 2005). Moreover, overexpres-
sion of AcrEF together can suppress the2014 Elsevier Ltd All rights reservedcell division defects of cells lacking envC
(Klein et al., 1991). Although the exact
function of AcrEF in this pathway is not
clear, these data provide evidence that
AcrEF-TolC plays a role E. coli cell
division.
Efflux pumps have gained a great deal
of attention for their role in conferring
resistance to antibiotics and protection
from other environmental stressors. In
addition, there is growing evidence
that efflux systems contribute to biofilm
formation and virulence, either by protect-
ing the bacterium from host assaults or by
secreting toxins into the host (Fernando
and Kumar, 2013; Krulwich et al., 2005).
Work on Caulobacter AcrAB2 and E. coli
AcrEF lends support to a model in which
this family of efflux pumps has important
functions in bacterial cell development
and/or division. At this point, it is unclear
whether these functions are direct or
indirect.
The discovery presented in this issue of
Chemistry & Biology provides the founda-
tion for further lines of inquiry into new
physiological roles for AcrAB family efflux
systems and the relationship between
efflux systems and microbial develop-
ment. Furthermore, this discovery estab-
lishes a role for polarity factors in
antibiotic resistance and raises the possi-
bility that targeted disruption of polarity
factors such as TipN could restore or
enhance toxicity of current antibiotics in
combination therapy, even in organisms
that are genetically resistant.REFERENCES
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